Cancer-associated fibroblasts confer ALK inhibitor resistance in EML4-ALK -driven lung cancer via concurrent integrin and MET signaling.
Hu Q, Remsing Rix LL, Desai B, Miroshnychenko D, Li X, Welsh EA, Fang B, Wright GM, Chaudhary N, Kroeger JL, Doebele RC, Koomen JM, Haura EB, Marusyk A, Rix U.
Hu Q, et al. Among authors: kroeger jl.
bioRxiv [Preprint]. 2024 Aug 28:2024.08.27.609975. doi: 10.1101/2024.08.27.609975.
bioRxiv. 2024.
PMID: 39253447
Free PMC article.
Preprint.